Role of PI3Kβ in functional platelet responses. (A) Role of PI3Kβ in promoting platelet aggregation. Platelets from p110flox/flox control (Cre−) or PF4-Cre/p110flox/flox (PF4-Cre+) mice were stimulated with thrombin, U46619, collagen, or convulxin, and aggregation was assessed using a Chrono-log dual-channel aggregometer under stirring at 900 rpm for 7 minutes. The profiles shown are representative of 5 independent experiments. Quantifications of the maximum of aggregation at 6 minutes are shown and are mean ± SEM of 5 independent experiments (right panels). (B) Role of PI3Kβ in promoting fibrin clot retraction. Photographs show the extent of clot retraction in wild-type and p110β-null platelet-rich plasma samples treated with 10 IU/mL thrombin. Quantification of the volume of serum extruded from the clot is shown. Results are the mean ± SEM of 3 independent experiments. (C) DIOC6-labeled platelets in whole blood from p110flox/flox control (Cre−) or PF4-Cre/p110flox/flox (PF4-Cre+) mice were perfused through fibrinogen-coated Bioflux plates at a shear rate of 1500 seconds for 5 minutes. Representative images at 5 minutes are shown. Images obtained with an epifluorescence microscope (Axiovert 200, Carl Zeiss; 40×/1.3 NA objective; 37°C) were captured with a CCD camera (CoolSnap HQ; Roper Scientific) and Metamorph software Version 6.2r6 (Universal Imaging Corp). Area covered by platelets was measured. Results shown are the mean ± SEM of 5 experiments. Statistical analysis: *P < .05; **P < .01; ***P < .005. (D) Thrombotic response of mice to ferric chloride injury of the carotid artery. Flow rates were measured in the carotid artery after exposure to 7% FeCl3 during 3 minutes. The experiment was stopped after 30 minutes. (i) For each genotype, the number of mice forming a stable occlusion is shown in black. The number of mice that formed an unstable occlusion that resolved is shown in gray. The number of mice that formed only a partial occlusion is shown in white. (ii) Representative flow traces for each case (stable occlusion, no occlusion, and unstable occlusion).